A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants

Trial Identifier:	D6402C00014
Sponsor:	AstraZeneca
NCTID::	NCT06651021
Start Date:	October 2024
Primary Completion Date:	October 2024
Study Completion Date:	October 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Chengdu, CN, 610041

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.